ViewsML to Address Biobank Access and AI Readiness at ISBER’s International Biospecimen Summit

ViewsML’s CEO will participate in two sessions to explore how biobanks can help startups build credible evidence and support the development of emerging AI models

Samplix Secures Backing to Accelerate Xdrop’s Commercial Expansion in Antibody Discovery

Samplix today announced financing led by WLanholding GmbH to expand commercial adoption of Xdrop, its single-cell screening platform that helps researchers identify and recover cells producing antibodies with the desired biological function.

eClinical Solutions Expands Executive Leadership with Three Strategic C-Suite Appointments

eClinical Solutions announced three new leadership appointments, including Chief Product Officer (Nathan Johnson), Chief People Officer (Brian Testa), and Chief Financial Officer (Jessica Allen).

Ceryx Medical manufactures first implantable heart failure device at King’s College London’s MAISI facility

Ceryx Medical and King’s College London today announced that the first implantable device has been manufactured at MAISI, the national facility for the Manufacture of Active Implants and Surgical Instruments.

Vivalink Powers Translational Medicine Through Continuous Physiologic Monitoring Across Healthcare and Clinical Research

Research at Brigham and Women’s Hospital and Ochsner Health demonstrates how continuous physiologic data helps translate clinical research into more actionable patient care - Continuous monitoring with wearables addresses a key challenge of translational medicine, allowing for uninterrupted data capture that can detect physiologic changes in a patient’s condition. - Vivalink’s Clinical Intelligence Platform enables automated monitoring, transmission and processing of patient data to help derive clinical insights. - Observing patients in their everyday settings gives researchers insights to their conditions outside of controlled settings, like in the hospital or at clinical trial sites.

CPHI targets Spain’s €38bn pharma market with new Barcelona event

Advanced Clinical appoints John Cargill as Chief Commercial Officer to accelerate global growth

Avenda Health Expands Unfold AI Platform to Support Intraoperative Prostate Cancer Care

Avenda Health enhances its AI-powered prostate cancer mapping platform, Unfold AI, to include new Surgery Mode, bringing patient-specific 3D cancer estimation maps directly into the operating room and giving surgeons an enhanced view of cancer anatomy during robotic prostate procedures.

ZeOmega Launches Jiva PrudenceAI to Embed Governed AI in Daily Health Plan Operations

Qureight appointed imaging CRO for Phase 3 SURPASS-IPF trial as partnership with Celea Therapeutics expands

Qureight, an end-to-end imaging CRO providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, today announced it has been selected by Celea Therapeutics as the imaging CRO to support Celea’s Phase 3 SURPASS-IPF clinical trial. Qureight will also present a joint poster with Celea Therapeutics at CHEST 2026 on quantitative imaging analysis completed during Celea’s phase 2b ELEVATE-IPF trial in idiopathic pulmonary fibrosis (IPF).

Meet CloudLIMS, the AI-Native LIMS, at Stand E91 @Lab Innovations 2026

Meet CloudLIMS, the AI-native LIMS with complimentary services, at Stand E91 in Hall 2 at Lab Innovations 2026, NEC Birmingham, UK, from November 4–5.

CluePoints Shortlisted for 2026 Scrip Awards Following 2023 and 2025 Wins

The two-time category winner secures finalist position in the Best Contract Research Organization (Specialist Providers) category.

WeGuide Secures A$1.9M to Commercialise Digital Biomarkers

WeGuide has been awarded A$1.9 million in CUREator+ funding to build a platform that makes commercial digital biomarker development faster and cheaper, starting with a mobility recovery biomarker with NeuRA.

Watchmaker Genomics Rethinks Whole Genome Sequencing with Expanse™

Baylor Genetics Study Finds Genome Sequencing Identifies Genetic Diagnoses in Nearly One-Third of Children with Intellectual Disability and Developmental Delay

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced the publication of its study "Diagnostic Yield of Genome Sequencing for Children with Intellectual Disability and Developmental Delay (ID/DD)” in Frontiers in Neurology.

Welo Life Sciences Announces Glass PV for AI-Enabled Pharmacovigilance Case Translation

Welo Life Sciences' Glass PV combines document extraction, specialist linguistic review, and automated layout reconstruction to simplify adverse event case translation.

Clinion’s Agentic AI Assistant Named Finalist for Technology Innovation of the Year at the Citeline Biotech Awards 2026

The recognition highlights Clinion’s work applying governed, multi-agent AI to clinical data management and study intelligence.

ELRIG and The Protein Society Announce Keynote Speakers for Protein Sciences in Drug Discovery 2026

• Prof Dame Carol Robinson (University of Oxford), Dr Andrew Doré (Isomorphic Labs) and Prof Paula Booth (King’s College London) to lead event taking place from 10–11 November at GSK Stevenage • Programme to focus on AI, machine learning and data-driven approaches across protein design, characterisation and therapeutic development

New Clearwater Report Finds 91% of Healthcare Organizations Cannot Verify AI Governance For Their Organization

HOPPR and CARPL.ai partner to give customers access to foundation models for building and fine-tuning radiology AI

CARPL.ai, the world's largest radiology AI marketplace and enterprise imaging AI platform, today announced a partnership with HOPPR, a company transforming how AI is developed for medical imaging. The collaboration gives healthcare providers access to HOPPR's foundation models to securely develop, fine-tune, and deploy custom radiology AI applications through the CARPL platform.